Abstract Using a focused glycan-gene microarray, we compared the glycosyltransferase (GT) and sulfotransferase gene expression profiles of human monocytes, dendritic cells (DCs) and macrophages (M s), isolated or differentiated from the same donors. Microarray analysis indicated that monocytes express transcripts for a full set of enzymes involved in the biosynthesis of multi-multiantennary branched N-glycans, potentially elongated by poly-Nacetyl-lactosamine chains, and of mucin-type Core 1 and Core 2 sialylated O-glycans. Monocytes also express genes involved in the biosynthesis and modification of glycosaminoglycans, but display a limited expression of GTs implicated in glycolipid synthesis. Among genes expressed in monocytes (90 out of 175), one third is significantly modulated in DCs and M respectively, most of them being increased in both cell types relative to monocytes. These changes might potentially enforce the capacity of differentiated cells to synthesize branched N-glycans and mucin-type O-glycans and to remodel cell surface proteoglycans. Stimulation of DCs and M s with lipopolysaccharide caused a general decrease in gene expression, mainly affecting genes found to be positively modulated during the differentiation steps. Interestingly, although a similar set of enzymes are modulated in the same direction in mature DCs and M s, cell specific genes are also differentially regulated during maturation, a phenomenon that may sustain functional specificities. Validation of this analysis was provided by quantitative real-time PCR and flow cytometry of cell surface glycan antigens. Collectively, this study implies an important modification of the pattern of glycosylation in DCs and M s undergoing differentiation and maturation with potential biological consequences.
Introduction
Glycosylation of proteins and lipids plays a crucial role in numerous biological processes including the regulation of immune and inflammatory responses (for reviews, [1] [2] [3] [4] [5] [6] ). During physiological conditions, glycans exert diverse functions on the immune system. By serving as ligands for glycan-binding proteins, such as classical adhesion molecules and lectins, they mediate immune cell differentiation, survival, adhesion, and trafficking [7] [8] [9] [10] [11] [12] [13] . During stress or infection, glycans also play a pivotal role by triggering or controlling immune cell signalling, migration, expansion and/or effector functions [10, [14] [15] [16] [17] [18] [19] [20] . Glycans exposed on the surface of professional antigen (Ag) presenting cells (APCs) are likely to be critical in many aspects of immune responses. They mediate host-pathogen interactions, influence their tropism and emigration and shape their biological functions after cell-to-cell contact. For instance, glycans play a part in the cross-talk between dendritic cells (DCs), the most potent APCs, and conventional T lymphocytes to modulate the strength and the quality of the acquired immune response [21] . Moreover, interactions of APCs with cells of the innate system, including natural killer cells, are supported by glycan/ counter-receptor interactions (for review, [22] ). More recently, a new concept has emerged showing that the production of glycolipids (glycosphingolipids, GSLs) by CD1d-expressing APCs is critical to activate Natural Killer T cells, a sub-population of innate/memory nonconventional T lymphocytes (for reviews, [23, 24] ). So far, although differentiation and activation of APCs, including monocytes, DCs and macrophages (M s), are accompanied by programmed remodelling of cell surface (glycosylated) molecules with potentially biologically important consequences, comparative analysis of the expression of genes involved in glycan biosynthesis (essentially glycosyltransferases, GTs) and modification (mainly sulfotransferases) has only been reported in DCs [25, 26] .
The mononuclear phagocyte system is composed by monocytes, DCs and M s, which contribute to tissue remodelling and homeostasis, inflammation and immune defence. Circulating monocytes, which constitute~5-10% of peripheral blood leukocytes in humans, give rise to tissue-resident M s as well as to other specialized cells such as osteoclasts and myeloid DCs [27] [28] [29] [30] . Dendritic cells are critical in the induction, expansion and regulation of immune responses (for reviews, [31] [32] [33] [34] ). Immature DCs principally locate at sites of Ag entry, where they are poorly immunogenic but efficient at capturing Ags through receptor-mediated endocytosis, macropinocytosis and phagocytosis. Upon activation by inflammatory factors and/or microbial components, DCs undergo a complex process of maturation allowing their traffic to T-cell areas of lymphoid tissues through modification of adhesion molecule and chemokine receptor expression. Dendritic cell maturation is also associated with high surface expression of Ag presenting and co-stimulatory molecules and with secretion of chemokines and bioactive mediators such as immuno-stimulatory cytokines. These factors are important to the downstream activation of numerous bystander innate immune cells, such as Natural killer (T) cells, and to promote T and B cell stimulation, expansion and polarisation [31] [32] [33] [34] . Although M s are much less potent in inducing primary immune response relative to DCs, they are crucial players in innate/acquired responses, in particular in immediate early defence against bacterial infection. The most prominent functions of M s are phagocytosis of intruding microorganisms and necrotic/apoptotic cells, bactericidal activity and rapid secretion of pro-inflammatory cytokines (for review, [27] ). Like DCs, activation/maturation of M s is mediated by engagement of various innate sensors, including Toll-like receptors (TLRs) (for reviews, [35, 36] ).
In the present study, we aimed to obtain general information relating to the expression of genes encoding GTs and sulfotransferases in human monocytes, DCs and M s isolated or differentiated from the same donor. We also aimed to compare the expression profile of these genes in immature versus mature (immuno-stimulatory phenotype) DCs and M s. To this end, we took advantage of a focused gene microarray (glycogene-chip v3, Consortium for Functional Glycomics) using the Affymetrix technology. The glyco-gene-chip v3 is a custom designed GeneChip expression array that utilizes 21 probes for each targeted transcript, ten more than are found on the commercially available GeneChip arrays such as the Hu133 Plus 2.0 array from Affymetrix. The additional probes used on this focused array increase the sensitivity for detection of low abundant transcripts (unpublished results, SRH). In the present study, we report that the differentiation and maturation processes affected the gene expression profiles of GTs and sulfotransferases in DCs and M s. Potential functional consequences for these changes are discussed.
Materials and methods

Reagents
Human recombinant GM-CSF was purchased from Peprotech (Rocky Hill, NJ) and IL-4 were from R&D systems (Abingdon, UK). LPS (type 055B5) was purchased from Sigma-Aldrich (St Louis, MI). Anti-CD14-microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany) were used for magnetic cell separation. The FITC-conjugated mouse anti-CD1a, anti-CD16, anti-CD209 (DC-SIGN) and anti-HLA-DR mAbs were obtained from Becton Dickinson (San Diego, CA). The APC-conjugated antiCD11c and anti-CD86 mAbs as well as the PE-conjugated mouse anti-CD80 and anti-CD14 mAbs were purchased by Becton Dickinson, whereas the anti-CD83 mAb was from Coulter (Miami, Flo). The anti-M mAb (clone RFD7) was furnished by AbD-Serotec (Abingdon, UK).
(clone H18A) and anti-Lewis x (Le x , clone 73-30) mAbs were from Seikagaku Corporation (Tokyo, Japan). The anti-sialyl Tn (clone HB-STn1), anti-sLe a (clone 2D3) and anti-Tn Ag (clone M0896) were from Dako (Glostrup, Denmark) and the anti-sialyl Le x (sLe x , clone CSLEX1) from Becton Dickinson. The anti-PSA Ab (clone 735) was kindly provided by Prof. R. Gerardy-Schahn (Medizinische Hochschule, Hannover, Germany). The FITCconjugated Sambucus nigra agglutinin (SNA) lectin was from Vector Laboratories (Burlingame, CA).
Preparation and stimulation of human DCs and M s
After giving informed consent, blood from healthy volunteers was collected (Etablissement Français du Sang, Lille). Peripheral blood mononuclear cells were prepared by density centrifugation on Ficoll-Paque. Blood monocytes were purified by positive selection over a MACS column using anti-CD14-conjugated microbeads. This purified cell population contained at least 95% CD14 + cells. An aliquot containing about 3-5×10 6 monocytes was immediately frozen to prepare RNA. Monocytes were then differentiated into DCs [37, 38] or into M s [39] by standard procedures. Briefly, monocytes were cultivated at 10 6 cells/ml for 6 days in RPMI 1640 with 10% heat-inactivated FCS (Invitrogen, Paisley, UK) containing 10 ng /ml IL-4 and 25 ng /ml GM-CSF or GM-CSF alone to obtain myeloid DCs [40, 41] or proinflammatory type I M s [42, 43] , respectively. At day 3, half of the culture medium was renewed by addition of fresh complete medium containing cytokines. At day 5, DCs and M s (at least 95% pure, as revealed by flow cytometry) were stimulated or not with LPS (100 ng/ml). Cells were collected after 18 h stimulation to prepare RNA or after 24 h for FACS analysis. Cell death was assessed by trypan blue exclusion and measurement of MTT oxydo-reduction (Sigma) in all culture conditions and neither exceeded 10%.
Microarray analysis of gene expression
Analysis of gene expression was conducted using a custom gene microarray (GLYCOv3 chip) produced by Affymetrix for the Consortium for Functional Glycomics (www. functionalglycomics.org), and containing probe sets for over 1,000 human genes including 199 human GTs and sulfotransferases. In this study, we focused our analysis on the expression of the 175 genes involved in the biosynthesis of N-glycans, mucin-type O-glycans, glycosaminoglycans, and glycolipids. Five to six independent experiments were performed for each condition. Total RNA was extracted using the Qiagen Mini kit according to the manufacturer's suggested protocol (Qiagen, Inc., Valencia, CA). The quality of the samples was checked with an Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA). For GT and sulfotransferase expression analysis, total RNA (1 µg) was amplified and biotin-labelled using the Bioarray MessageAmp II-Biotin Enhanced Kit from Ambion and then hybridized to the GLYCOv3 array. Hybridization and scanning of samples was performed using standard Affymetrix protocols for GeneChip expression arrays based on methods originally described in [44] (protocol available at http://affymetrix.com). Chips were scanned using the Affymetrix ScanArray 3,000 using default settings and a target intensity of 250 for scaling. The transcriptional profile was evaluated in independent cell preparations, each derived from a different donor and one chip per biological sample was run. Expression calls indicate whether a gene is detected above background using the GC-matched bins as background measurement. For this purpose the Fisher's Combined P Method [45] as implemented in the R program software (R is available as Free Software under the terms of the Free Software Foundation's GNU General Public License). The Fisher's Combined P method threshold was adjusted so that the expression calls were consistent with the present and absent calls as implemented in the Affymetrix Microarray Suite V5. Intensity values were normalized using Robust Multichip Average (RMA) [46, 47] . The Limma package in the R software was used for the Anova analysis. The fold changes and standard errors were estimated by fitting a linear model for each gene and empirical Bayes smoothing was applied to the standard errors for all the samples at the same time. 
Flow cytometry analysis
Cells were collected in PBS containing 2 mM EDTA at 4°C and labelled as previously described [37] . Cells were incubated for 30 min in aliquots of 2×10 5 cells in 50 µl of PBS containing 2% FCS with or without Abs (10 µg/ml) or the lectin SNA (40 µg/ml). After washing, cells were directly analyzed for the conjugated mAbs. In some cases, cells were incubated with Phycoerythrin-conjugated goat IgG anti-mouse IgG or IgM (Southern Biotechnology, Birmingham, Al). After 30 min incubation, labelled cells were washed and analyzed. Flow cytometry data were acquired on viability-gated cells using a FACSCalibur flow cytometer and analyzed with the CellQuest software system (BD Biosciences). Results are expressed as the mean fluorescence intensity (MFI) obtained with specific mAbs or lectins minus the value obtained with the isotype control (ΔMFI).
Results
Expression profile of GT and sulfotransferase genes in monocytes
We first analyzed the expression pattern of GT and sulfotransferase genes involved in the biosynthesis of Nglycans, mucin-type O-glycans, glycosaminoglycans (GAGs), and glycolipids in circulating peripheral blood monocytes. We found that, among the 175 analyzed genes (200 probe set), 90 are significantly expressed in human monocytes (five donors). Table 2 shows the average expression signals of these genes, which are clustered according to the specificities of the enzymes that they encode. As shown in Table 2 , transcripts for fucosyltransferases (FucT), and to a lesser extent for glucosyltransferases (GlcT), glucuronosyltransferases (GlcAT) and mannosyltransferases (ManT) are expressed at a lower level compared to those of the other subfamilies. Interestingly, several genes involved in the first steps of Nglycosylation, in particular in the formation of the oligosaccharidyltransferase complex such as DAD1 (probes #92/93), RNP1 (#94), RNP2 (#95) and DDOST (#96), are highly expressed in monocytes. Concomitantly, genes encoding enzymes involved in both N-glycan branching (i.e. MGAT5B (#34), MGAT2 (#36), MGAT4B (#37/38/41) & MGAT1 (#40)) and poly-N-acetyl-lactosamine chain elongation (i.e. B3GNT1 (#29), B3GNT2 (#30), B3GNT8 (#35), IGNT2 (#31), B4GALT3 (#22) and B4GALT4 (#17)) are also well expressed, suggesting that monocytes synthesize N-glycans carrying di, tri, and tetraantennary structures, possibly elongated by poly-N-acetyllactosamine chains. In parallel, monocytes also highly express B4GALT5 (#24) and B4GALT1 (#25), two genes encoding type 2 disaccharide (Galβ1-4GlcNAc) synthesising enzymes, together with fucosyltransferases (FUT4 (#6) and FUT7 (#5)) and sialyltransferase (ST3GAL6 (#58)) using type 2 disaccharide as acceptor substrate. This indicates that monocytes possess a full set of enzymes for the biosynthesis of Le x and sialyl (s)Le x in terminal position of oligosaccharide chains. In agreement with previous reports [48, 49] , FACS analysis confirmed expression of sLe x , but not Le x , on monocytes (Table 3) . At the opposite, the β1,3-galactosyltransferases (β3-Gal T1, β3-Gal T2, β3-Gal T5 and β3-Gal T7) involved in the biosynthesis of type I disaccharide unit (Galβ1-3GlcNAc) are not significantly expressed in monocytes. This correlates with the absence of type I derived blood group Ags, such as Le a , sLe a or Le b , as revealed by FACS analysis (Table 3) . Polypeptide GalNAc-transferases, the mucintype O-glycan initiating enzymes, are also well produced in monocytes. Seven different enzymes (i.e. ppGalNAc T3 (#7), T10 (#8/12), T7 (#9), T11 (#10), T2 (#11), T1 (#14), T6 (#15/16)) are fairly or highly expressed, suggesting a very good capacity for monocytes to synthesise O-glycan chains. In parallel, monocytes also express the Core 1 β3-Gal T1 (CIGALT1, #18), the Core 2 β6-GlcNAc T1 (GCNT1, #28) and several core 1-specific sialyltransferases (i.e. ST6GalNAc IV (#59), ST6GalNAc II (#61), and ST3Gal I (#65), but other core-specific enzymes such as Core 2 β6-GlcNAc T3, Core 2 and 4 β6-GlcNAc T4 or Core 3 β3-GlcNAc T6 are not detected. Moreover, monocytes do not express a transcript for ST6GalNAc I, the enzyme responsible for the synthesis of sialyl-Tn (NeuAcα2-6GalNAcα1-O-Ser/Thr). These data, together with the absence of Tn (GalNAcα1-O-Ser/Thr) or sialylTn Ags (FACS analysis, data not shown), suggest that monocyte O-glycan chains are mainly Core 1 and Core 2 sialylated glycans. This is in line with recent data reporting mass spectrometry O-glycan profiling of monocytes [26] . Besides N-glycan and mucin-type O-linked glycan genes, monocytes express genes encoding for enzymes involved in GAG biosynthesis, including those implicated in the tetrasaccharide linker, chondroitin sulphate and heparan sulfate copolymerases, and for modification enzymes such as 5-epimerase and numerous sulfotransferases (Table 2) . Finally, although the expression levels of the two key GTs controlling the first step of GSL synthesis (glucosylceramide synthase UGCG, #43) and lactosylceramide synthase) are low or undetectable, monocytes transcribe several genes encoding enzymes involved in GSL glycosylation. For instance, in the Globo series of GSLs, the G b4 synthase (GBGT1, #13), but not the G b3 synthase, is highly expressed in monocytes. In the Ganglio series, the G M3 synthase (ST3Gal V, #64) is highly expressed but both [38, 50, 51] . We investigated whether in vitro differentiation of DCs or M s from monocytes leads to changes in the level of GT and sulfotransferase transcript expression. The quality of the differentiated cells was assessed after selection and differentiation by flow cytometry. As shown in Table 3 , clear phenotypic differences between monocytes, DCs and M s was observed. Unlike M s and monocytes, immature DCs express the canonical markers CD1a and DC-SIGN (CD209). At the opposite, M s, but not DCs, produce CD16 and RFD7. Monocytes are strongly positive for CD14, a marker lost during their differentiation, and some cells are also positive for CD16. Furthermore, transcriptomic analysis confirmed that cellspecific markers are expressed by DCs, such as the lectins DEC-205, DC-SIGN (CD209) and DC immunoreceptor (DCIR), and by M s, such as the scavenger receptors collectin 12 and LOX-1 or are common to both cell types such as the macrophage mannose receptor (CD206) (data not shown).
As shown in heatmap representation (Fig. 1) , in both DCs and M s, a significant number of GT and sulfotransferase genes (31/90 (34 %) and 27/90 (30 %), respectively) are significantly (P < 0.05) changed in their expression levels (fold change > 1.4). Indeed, 21 GT and sulfotransferase transcripts are increased and only ten are decreased in DCs, whilst in M s, 22 GT and sulfotransferase mRNAs are increased and five are decreased. To validate these changes, we performed quantitative real-time PCR (qPCR) using biological samples (three to five) independent of those used in the gene chips analysis. To this end, we focused on genes with the highest expression variation and/ or involved in specific pathways. As Table 4 shows, and among the tested genes, the qPCR analysis confirmed data obtained by the micro-array approach. Strikingly, DCs and M s exhibit similarities in their pattern of GT and sulfotransferase transcript expression, indicating that the majority of these genes are modulated in the same direction during the differentiation processes (Fig. 1 ). Among them, several genes coding for enzymes involved in the first steps of N-glycan biosynthesis are increased (albeit moderately) in differentiated cells, such as those directly associated to the biosynthesis of the lipid-linked precursor of Asn-linked glycans, the dolichol-PP-oligosaccharide (ALG1 (#53), ALG2 (#54), ALG5 (#47), ALG8 (#46) and ALG9 (#51)) and to the transfer of the oligosaccharide onto the nascent protein (DAD1 (#93) and DDOST (#96)). Variation of gene Table 2 are indicated beside the heatmaps. Details for determining these significant differentially transcripts are presented in the Methods section transcripts are also observed for GTs that selectively act in the Golgi processing of N-glycans, such as the N-acetylglucosaminyltransferase MGAT2 (#36), MGAT4A (#27), and particularly the β3-GlcNAc T1 (# 29), the latter being essential for the synthesis of poly-N-acetyllactosamine chains [52] . These enzymes might contribute to an enforced capacity of differentiated cells to synthesise branched poly-N-acetyllactosamine N-glycans chains. Interestingly, the polysialyltransferase ST8Sia IV (#57), one of the key enzymes of polysialic acid (PSA) biosynthesis, a structure usually found on neural cell adhesion molecule [53] , is over-expressed in DCs. However, in contrast with a recent report describing PSA expression on neuropilin-2 [54] , we failed to detect PSA expression on the DC surface (not shown). This contrasting result may be explained by differences in the experimental protocols used to generate DCs, which could result in the lack of neuropilin-2 and therefore of PSA. Differentiation is also accompanied to changes in the expression of GTs involved in O-linked glycan synthesis. Compared to monocytes, the gene encoding the polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAcT6 or GALNT6, #16), is increased in both DCs and M s. In parallel, ppGalNAcT10 (GALNT10, #12) is decreased in both differentiated cells and ppGalNAcT3 (GALNT3, #7) in DCs. This indicates that, along with an enforced N-type glycosylation, the mucin-type O-linked glycosylation might also be modified during DC and M differentiation. FUT11, the gene encoding the putative α1,3/ 4-fucosyltransferase 11 (#3) is also increased in both DCs and M s. This might explain the increased expression of sLe x in immature DCs (~27 fold compared to monocytes), as indicated by FACS analysis ( Fig. 1a and c) . In agreement with a recent study reporting a high α2,6-linked sialic acid density in immature DCs [57] , ST6Gal I (#63) is over-expressed in DCs. The enhanced (~3-fold) exposure of α2,6-linked sialic acid on differentiated cells, relative to monocytes, was confirmed by flow cytometry using the SNA lectin ( Table 3 ). The lactotriaosylceramide (Lc3) synthase (B3GNT5, #24) and Table 4 mRNA expression of GT and sulfotransferase genes during the differentiation of DCs and M s, as analyzed by qPCR # in Table 2 Common RNAs from resting monocytes or from unstimulated DCs or M s were harvested after differentiation and mRNA copy numbers were measured by qPCR. Data are normalized to expression of β-actin and are expressed as fold increase over average gene expression in monocytes. Data represent the mean ± SEM of three to five independent donors the Forssman synthase (GBGT1, #13), the enzyme that converts the Pk Ag into the Forssman Ag, are significantly increased in DCs, but not in M s. These latter observations suggest potential differences in the synthesis of globo and (neo)lacto series of GSLs between DCs and M s, which could have important consequences on the fine tuning of membrane microdomain organization and cell signalling.
Comparison of GT and sulfotransferase gene expression in mature DCs and M s, relative to immature cells
As a next step, we compared the expression levels of GT and sulfotransferase transcripts in immature versus mature DCs or M s. To this end, cells were stimulated for 18 h with the canonical TLR4 agonist lipopolysaccharide (LPS). As expected, LPS strongly increases the expression of CD80 and CD86 in DCs, and at a lower level in M s, whilst that of HLA-DR and CD83 was only induced in mature DCs (Table 3 ). Microarray analysis revealed that the expression of lectins, which are upregulated during the differentiation, is mainly repressed after maturation (not shown), as confirmed by flow cytometry for DC-SIGN (CD209) ( Table 3) . Thus, LPS treatment results in dramatic changes in DC and M phenotype.
Compared to immature cells, LPS treatment is accompanied by a variation of some GT and sulfotransferase gene expression, in particular in DCs. Among modulated genes, 23 genes in DCs and 25 genes in M s are significantly decreased after stimulation, respectively (Fig. 2) . On the other hand, in DCs and M s, respectively, 15 and 6 genes are increased at 18 h compared to resting cells. Most of these variations were confirmed by qPCR on RNA from three to five samples different from those used in the gene chips analysis (Table 5) . Strikingly, LPS treatment preferentially down-modulated genes found to be positively regulated during the differentiation steps (nine for DCs and 11 for M s). As an example, MGAT4A (#27), DDOST (#96), DAD1 (#92), GLCE (#89), HS2ST1 (#69) and B3GNT1 (#29), which are increased during DC and M differentiation, are decreased in LPS-stimulated DCs and M s. A similar observation is made for ST6Gal I (#63), which is increased during the differentiation steps, but strongly decreased after LPS treatment. This was however not accompanied by a decreased binding of SNA on mature cells (Table 3) . With the notable exception of core 1 β3Gal T1 (C1GALT1, #18) and ST3GAL1 (#65), which are increased in stimulated DCs, most of the O-linked glycan enzymes are decreased after stimulation. In particular, the core 2 β6 GlcNAc T1 (GCNT1, #28) is decreased in both mature DCs and M s. Altogether, these observations are in agreement with [25, 26] and indicate that mature cells have a reduced capacity for synthesising mucin-type O-glycans, which might be reduced to sialylated core 1. In agreement with the general picture that maturation inversely modulates the expression of genes affected during the differentiation step, genes such as B4GALT5 (#24), EXT1 (#87), CHST12 (#72) and GALNT10 (#8), found to be down-regulated during the differentiation steps, are generally increased in mature DCs or M s (Fig. 2) . However, notable exceptions are observed, for example for genes only modulated during the maturation, but not during the differentiation process. These genes include FUT4 (#6), an α3-fucosyltransferase involved in the synthesis of selectin ligands, and the core 1 β3-Gal T1 (#18), for which expression is unchanged during differentiation, but increased in both mature DCs and M s. We also noticed that some genes including B3GNT2 (#30), the sulfotransferase CHST12 (#72), B4GALT4 (#17), the copolymerase EXTL2 (#81) and ST8SIA4 (#57), found to be enhanced during the differentiation, are also increased during the maturation of DCs and/or M s (Fig. 2) . Finally, LPS treatment leads to cell-specific differences. The first difference concerns the expression of genes, including the pp-GalNAc T2 (#11), the β3-GlcNAc T2 (#30), the Nacetylglucosamine 6-O-sulfotransferase 7 (CHST7, #74) and 14 (CHST14, #73), the sialyltransferases ST6GalNAc II (#61) and ST3Gal VI (#58) and the chondroitin GalNActransferase 2 (CSGALNACT2, #83), which are strongly modified (positively or negatively) in LPS-treated DCs (Fig. 2b) , but unchanged in stimulated M s (Fig. 2c) . Similarly, compared to M s, transcripts for some GSLspecific GTs are enhanced in mature DCs, but not M s.
These include the glucosylceramide synthase UGCG (#43) and the G M3 synthase (ST3GAL5, #64), the later being involved in the synthesis of ganglio series (a, b and c) of GSLs. Flow cytometry analysis, however, revealed no significant increase of G M3 cell surface expression after LPS stimulation and no G D3 synthesis, in correlation with the low expression of ST8SIA1. Although not fully GSL specific, ST3Gal I (#65), which is implicated in the synthesis of complex gangliosides (G M1b /G D1a /G T1b /G Q1c ) is also increased in DCs, but not in M s. RNAs from unstimulated or LPS-stimulated DCs or M s were harvested after 18 h stimulation and mRNA copy numbers were measured by qPCR. Data are normalized to expression of β-actin and are expressed as fold increase over average gene expression in unstimulated DCs or M s. Data represent the mean ± SEM of three to five independent donors a finding confirmed by FACS analysis. The synthesis of sLe x on monocytes might be important in the extravasation and infiltration of these cells into peripheral sites, where DCs and M s differentiate [27] . Monocytes also synthesize genes encoding GTs involved in GAG (heparin and chondroitin sulfate) biosynthesis and encoding sulfotransferases involved in their modification. On the other hand, judging by the low expression levels of genes encoding GT specifically implicated in GSL synthesis, monocytes seem to display a limited capacity to produce glycolipids.
Because differentiation of DCs and M s is accompanied by programmed remodelling of cell surface glycans with biologically important consequences, we next compared GT and sulfotransferase gene expression in in vitro differentiated cells, relative to monocytes. Previous reports have shown that monocyte-to-M , and possibly monocyteto-DC differentiation, is associated with modulation of~1 to 2 % of the global transcriptome [58] . We found that, among genes found to be significantly expressed in monocytes,~30 % are modulated (mostly increased) in both DCs and M s. These gene array data were validated by qPCR using biological samples independent of those used in the gene chips analysis. This suggests that GT and sulfotransferase genes are relatively sensitive to the differentiation steps and that DCs and M s present an enhanced capacity to produce glycans compared to monocytes. Among biosynthetic pathways, it seems that globally, transcripts for enzymes involved in N-glycosylation pathway, as well as in mucin-type O-glycan and GAG synthesis, are mainly affected. In particular, GT genes involved in N-glycan synthesis are generally increased in differentiated cells. The general picture is that transcripts encoding enzymes involved in both initiation and elongation of N-and O-glycan chains are enhanced during differentiation. Genes encoding endoplasmic reticulum enzymes involved in dolichol cycle or encoding oligosaccharidyltransferase subunits are increased in differentiated cells. In the same time, enzymes involved in both branching and elongation of poly-N-acetyllactosamine chains of Nglycans, are also augmented. MALDI-TOF analysis of Nglycans in DCs has previously shown the presence of sialylated tri-and tetra-antennary N-glycans, potentially elongated with poly-N-acetyllactosamine and decorated with Lewis-type epitopes [25] . Similarly, several genes encoding polypeptide N-acetylgalactosaminyltransferases are increased in differentiated cells suggesting an enhanced synthesis of O-glycans. Micro-array analysis also shows the preferential expression of several enzymes involved in type II (Galβ1-4GlcNAc) terminal unit biosynthesis in monocytes derived-cells. Altogether, these data indicate an enforced capacity of differentiated cells to synthesize type II blood group epitopes exposed at the surface that fits well with the highest sLe x expression in immature DCs and M s, as indicated by FACS analysis. It is possible that, through selectin member interactions, sLe x might be involved in the migration of DCs and M s and/or in their interactions with immune cell types (including T cells) [59] . Interestingly enough, specific enzymes involved in the synthesis of other glycan determinants potentially exposed on the cell surface to interact with counter-receptors are positively modulated in differentiated cells. For instance, over-expression of ST6GAL1 transcript in immature DCs, an enzyme that elaborates the terminal sequence NeuAcα2-6Galβ1-4GlcNAc on N-linked (such as CD45) and O-linked glycoproteins, is in agreement with the high α2-6-linked sialic acid density in immature DCs [57] and could be important in many situations. Indeed, this sialylated sequence represents the glycan ligand for CD22 (Siglec-2), a molecule known to negatively regulate signalling events [15] and implicated in the regulation of Siglec-mediated cell death [60] . Within the proteoglycan family, important changes in the expression of genes encoding enzymes implicated in the sulfatation of GAGs and in the synthesis of proteoglycans (i.e. members of the syndecan family) are observed in both DCs and M s. This might result in important remodelling of proteoglycans on their surface, potentially giving new counter-receptors, relative to monocytes. Collectively, although monocytes, DCs and M s all belong to the mononuclear phagocyte system, they display a distinct profile of GT and sulfotransferase expression as a result of cell differentiation. Micro-array analysis has revealed clear analogies between DCs and M s in terms of GT and sulfotransferase transcript expression, without a real clear gene expression signature. Whether the few differences in gene expression between DCs and M s could account for functional differences is an open question that deserves further investigations.
Since glycosylation-related genes are modulated during stress conditions [61] [62] [63] , we next investigated whether GT and sulfotransferase transcripts could be modulated in DCs and M s in response to LPS. Maturation/activation of DCs and M s results in a profound remodelling of cell surface markers (chemokine receptors, co-stimulatory molecules) with important functional consequences. However, the impact of maturation/activation on glycan synthesis in these cells has only been recently investigated for DCs [25, 26] . To address this question more in depth, cells were stimulated with LPS, one of the most potent TLR activator. Compared to immature cells, LPS treatment was accompanied by a general decrease of GT and sulfotransferase gene expression in both DCs and M s and mainly affects genes that were found to be modulated during DC and M differentiation. For instance, in DCs,~40 % of genes increased during differentiation are decreased during maturation. Notably, excepted GTs involved in the synthesis of sialylated core 1 O-glycans, most enzymes involved in O-linked glycosylation, including the core 2 β6 GlcNAc T1 (GCNT1), are decreased after LPS stimulation. These findings are in line with recent reports [25, 26] , although our data do not confirm the total loss of sLe x , known to require core 2 structures, on mature DCs. This discrepancy may be explained by experimental differences to induce DC maturation (TNF-α plus PGE 2 vs. LPS). Of note, several genes are also increased during DC maturation such as those involved in GAG biosynthesis (sulfotransferases and co-polymerases). This suggests an enhanced synthesis of HS in mature cells that can be implicated in signaling functions of heparin-binding growth factors and chemokines [55, 64] . Transcripts for enzymes implicated in the production of globo-series (B3GALNT1, GBGT1) and ganglio-series of GSLs (ST3GAL5, ST3GAL1) are specifically enhanced in mature DCs, relative to M s. This, and the enhanced expression of ceramide glucosyltransferase (UGCG) in DCs, strongly suggests that a profound change of GSL metabolism operates in DCs undergoing maturation. The relevance of this finding is still unknown and deserves further investigations. Glycolipids have been clearly demonstrated to be involved in differentiation, proliferation and migration of neural cells in mammalian central nervous system, and changes in GSL expression in mature DCs might be important in their immunostimulatory functions. Interestingly, TLR-stimulated DCs have recently been shown to generate new or increasing amounts of glycolipid Ags able to activate different subsets of lipidreactive innate/memory T cells, via the CD1 molecules [65] [66] [67] [68] [69] . This pathway is believed to play an important role in innate responses to pathogens and to polarize acquired responses [23, 70] . Altogether, these data suggest that by affecting certain enzymes of the GSL pathway, TLR triggering in DCs could play an important part in innate/ acquired responses.
In conclusion, we herein report the GT and sulfotransferase gene expression profiling in DCs and M s, both in basal and stress (pro-inflammatory) conditions. We show that differentiation (monocyte-to-DC and monocyte-to-M ) and maturation processes are associated with significant changes in GT and sulfotransferase gene expression. Interestingly, although DCs and M s express a comparable pattern of enzymes, cell specific genes are also differentially modulated during the differentiation and maturation processes, a phenomenon that may sustain functional specificities.
